NB466226
Novus Biologicals™ VEGFR2/KDR/Flk-1 Antibody (olinvacimab), Novus Biologicals™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB466226-Each-of-1 | In Stock | ₹ 67,540.21 |
NB466226 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 67,540.21
GST (18%): ₹ 12,157.238
Total Price: ₹ 79,697.448
Antigen
VEGFR2/KDR/Flk-1
Classification
Monoclonal
Conjugate
Unconjugated
Gene Accession No.
P35968
Host Species
Human
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype
IgG1
Applications
Flow Cytometry, ELISA, Functional Assay
Clone
olinvacimab
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen
VEGFR2/ KDR/ CD309
Quantity
1 mg
Research Discipline
Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez)
3791
Target Species
Human
Form
Purified
Description
- VEGFR2/KDR/Flk-1 Monoclonal antibody specifically detects VEGFR2/KDR/Flk-1 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay
Compare Similar Items
Show Difference
Antigen: VEGFR2/KDR/Flk-1
Classification: Monoclonal
Conjugate: Unconjugated
Gene Accession No.: P35968
Host Species: Human
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype: IgG1
Applications: Flow Cytometry, ELISA, Functional Assay
Clone: olinvacimab
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen: VEGFR2/ KDR/ CD309
Quantity: 1 mg
Research Discipline: Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez): 3791
Target Species: Human
Form: Purified
Antigen:
VEGFR2/KDR/Flk-1
Classification:
Monoclonal
Conjugate:
Unconjugated
Gene Accession No.:
P35968
Host Species:
Human
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype:
IgG1
Applications:
Flow Cytometry, ELISA, Functional Assay
Clone:
olinvacimab
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen:
VEGFR2/ KDR/ CD309
Quantity:
1 mg
Research Discipline:
Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez):
3791
Target Species:
Human
Form:
Purified
Antigen: VEGFR2/KDR/Flk-1
Classification: Monoclonal
Conjugate: Unconjugated
Gene Accession No.: P35968
Host Species: Human
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype: IgG1
Applications: Flow Cytometry, ELISA, Functional Assay
Clone: olinvacimab
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen: VEGFR2/ KDR/ CD309
Quantity: 100 μg
Research Discipline: Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez): 3791
Target Species: Human
Form: Purified
Antigen:
VEGFR2/KDR/Flk-1
Classification:
Monoclonal
Conjugate:
Unconjugated
Gene Accession No.:
P35968
Host Species:
Human
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype:
IgG1
Applications:
Flow Cytometry, ELISA, Functional Assay
Clone:
olinvacimab
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2
Immunogen:
VEGFR2/ KDR/ CD309
Quantity:
100 μg
Research Discipline:
Angiogenesis, Apoptosis, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Phospho Specific, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases
Gene ID (Entrez):
3791
Target Species:
Human
Form:
Purified
Antigen: IL-6
Classification: Monoclonal
Conjugate: Unconjugated
Gene Accession No.: P05231
Host Species: Human
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype: IgG1
Applications: Flow Cytometry, ELISA, Functional Assay
Clone: Merck patent anti-IL-6
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: B-cell differentiation factor, B-cell stimulatory factor 2, BSF2, BSF-2, CDF, CTL differentiation factor, HSF, hybridoma growth factor, IFNB2, IFN-beta-2, IL-6, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6
Immunogen: IL-6/ IFNb2
Quantity: 50 μg
Research Discipline: Adaptive Immunity, Biologically Active Proteins, Cancer, Cell Cycle and Replication, Cytokine Research, Immunology, Innate Immunity, Neuroscience
Gene ID (Entrez): 3569
Target Species: Human
Form: Purified
Antigen:
IL-6
Classification:
Monoclonal
Conjugate:
Unconjugated
Gene Accession No.:
P05231
Host Species:
Human
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype:
IgG1
Applications:
Flow Cytometry, ELISA, Functional Assay
Clone:
Merck patent anti-IL-6
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
B-cell differentiation factor, B-cell stimulatory factor 2, BSF2, BSF-2, CDF, CTL differentiation factor, HSF, hybridoma growth factor, IFNB2, IFN-beta-2, IL-6, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6
Immunogen:
IL-6/ IFNb2
Quantity:
50 μg
Research Discipline:
Adaptive Immunity, Biologically Active Proteins, Cancer, Cell Cycle and Replication, Cytokine Research, Immunology, Innate Immunity, Neuroscience
Gene ID (Entrez):
3569
Target Species:
Human
Form:
Purified
Antigen: IL-6
Classification: Monoclonal
Conjugate: Unconjugated
Gene Accession No.: P05231
Host Species: Human
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype: IgG1
Applications: Flow Cytometry, ELISA, Functional Assay
Clone: Merck patent anti-IL-6
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias: B-cell differentiation factor, B-cell stimulatory factor 2, BSF2, BSF-2, CDF, CTL differentiation factor, HSF, hybridoma growth factor, IFNB2, IFN-beta-2, IL-6, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6
Immunogen: IL-6/ IFNb2
Quantity: 1 mg
Research Discipline: Adaptive Immunity, Biologically Active Proteins, Cancer, Cell Cycle and Replication, Cytokine Research, Immunology, Innate Immunity, Neuroscience
Gene ID (Entrez): 3569
Target Species: Human
Form: Purified
Antigen:
IL-6
Classification:
Monoclonal
Conjugate:
Unconjugated
Gene Accession No.:
P05231
Host Species:
Human
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype:
IgG1
Applications:
Flow Cytometry, ELISA, Functional Assay
Clone:
Merck patent anti-IL-6
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias:
B-cell differentiation factor, B-cell stimulatory factor 2, BSF2, BSF-2, CDF, CTL differentiation factor, HSF, hybridoma growth factor, IFNB2, IFN-beta-2, IL-6, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6
Immunogen:
IL-6/ IFNb2
Quantity:
1 mg
Research Discipline:
Adaptive Immunity, Biologically Active Proteins, Cancer, Cell Cycle and Replication, Cytokine Research, Immunology, Innate Immunity, Neuroscience
Gene ID (Entrez):
3569
Target Species:
Human
Form:
Purified